Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Johnson & Johnson MedTech launches new 2D ICE catheter
The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists.
Johnson & Johnson MedTech ordered to pay $147M for antitrust violations
The company told Cardiovascular Business it respectfully disagrees with the jury's decision and is evaluating all possible legal options going forward. The Association of Medical Device Reprocessors, meanwhile, celebrated the news.
Cardiologists are first in world to use new cooling device to terminate AFib during surgery
Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks.
World’s first leadless LBBAP procedures linked to ‘promising’ outcomes
Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures.
AI predicts LBBB risk in TAVR patients prior to treatment
The authors tested out a variety of machine learning techniques, including large language models and more traditional algorithms. They focused on data that can be gathered prior to treatment, ensuring cardiologists know as much as possible before the procedure.

Confirmed: Watchman FLX LAAC device safe for nonvalvular AFib patients

New two-year findings, presented at TVT 2021, suggest that the Watchman FLX device is a safe alternative to long-term oral anticoagulation therapy.

Increased physical activity after ICD implantation lowers the risk of death, hospitalization

Participation in cardiac rehabilitation programs remains low, the authors wrote, but this study showed that it can make a significant impact on patient outcomes.

healthcare value value-based care money dollar

Catheter ablation a cost-effective option for HF patients with AFib

Researchers shared their full analysis in the Journal of the American Heart Association.

Yes, Apple’s iPhone can interfere with implantable cardiac devices—here’s what you should know

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.

Catheter ablation tops medication alone for treating AFib—but the risk of complications remains

Catheter ablation is associated with better outcomes for AFib patients, researchers noted, but beginning treatment with just antiarrhythmic medications may be the most practical option.

COVID-19 coronavirus burnout depression pandemic

10 helpful tips for heart rhythm patients as the COVID-19 pandemic continues

The new analysis, published in Circulation: Arrhythmia and Electrophysiology, was designed to help patients stay informed and avoid unnecessary stress during this challenging time.

Why early rhythm control therapy is so important for atrial fibrillation patients

The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.

Cloud-based imaging spinoff inHeart raises $4.2M for AI-based heart arrhythmia solution

It’s cloud software turns preoperative medical images into a 3D “digital twin” of the patient’s heart enabling providers to plan procedures and navigate instruments during surgery.

Electrophysiology

Johnson & Johnson MedTech launches new 2D ICE catheter

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

AI predicts LBBB risk in TAVR patients prior to treatment